RCS - Tristel PLC - Investor results presentation

TristelAnnouncement

14/01/2019 12:00

RNS Number : 0303N
Tristel PLC
14 January 2019
 


 
Tristel plc
("Tristel" or the "Company")
 
Investor results presentation
 
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, will announce the Company's interim results for the six months ended 31 December 2018 on Monday 25 February 2019.
 
Investor presentations
Paul Swinney, CEO, and Liz Dixon, CFO, will present the Company's results in two separate events open to all investors. The same presentation will be given at both events which are being held at different times to offer convenient options for those wishing to attend.
 
Two presentations will take place on Monday 25 February 2019 at the following times and location:
·   10.30 for a 10.45 start at The Brand Exchange, 3 Birchin Ln, London, EC3V 9BW
·   16.45 for a 17.00 start at The Brand Exchange, 3 Birchin Ln, London, EC3V 9BW
The presentations will be followed by refreshments. 
 
If you would like to register for either investor presentation, or require further information, please contact Lianne Cawthorne at Walbrook PR on 020 7933 8780 or email tristel@walbrookpr.com ensuring you detail in your email which presentation you would like to attend.
 
The results presentation will be made available on the Company's website www.tristel.com on the day of results.
 
 
 
For further information please contact:       
 




Tristel plc


Tel: 01638 721 500




Paul Swinney, Chief Executive Officer


 




Liz Dixon, Finance Director


 




 


 




Walbrook PR Ltd


Tel: 020 7933 8780 or tristel@walbrookpr.com




Paul McManus


Mob: 07980 541 893




Lianne Cawthorne


Mob: 07584 391 303




 


 




finnCap


Tel: 020 7220 0500




Geoff Nash/ Giles Rolls (Corporate Finance)


 




Alice Lane (ECM)


 



 
 
 



 
 
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRABIMBTMBABBPL